Shanghai Titan Scientific Co. Ltd. A Net Assets
Shanghai Titan Scientific Co. Ltd. A net assets. Based on the latest financial reports, Shanghai Titan Scientific Co. Ltd. A (688133) has net assets worth CN¥2.79 Billion CNY (≈ $408.13 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.86 Billion ≈ $710.45 Million USD) and total liabilities (CN¥2.07 Billion ≈ $302.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 688133 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.79 Billion |
| % of Total Assets | 57.45% |
| Annual Growth Rate | 31.81% |
| 5-Year Change | 74.87% |
| 10-Year Change | 1318.07% |
| Growth Volatility | 43.48 |
Net Assets of Shanghai Titan Scientific Co. Ltd. A (2013–2025)
Net assets of Shanghai Titan Scientific Co. Ltd. A from 2013 to 2025. This chart illustrates how Shanghai Titan Scientific Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. See 688133 equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Shanghai Titan Scientific Co. Ltd. A (2013–2025)
The table below shows the annual net assets of Shanghai Titan Scientific Co. Ltd. A from 2013 to 2025. For live market cap and overall valuation, see Shanghai Titan Scientific Co. Ltd. A market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.83 Billion ≈ $413.53 Million |
-1.56% |
| 2024-12-31 | CN¥2.87 Billion ≈ $420.07 Million |
+0.72% |
| 2023-12-31 | CN¥2.85 Billion ≈ $417.07 Million |
+3.02% |
| 2022-12-31 | CN¥2.77 Billion ≈ $404.85 Million |
+71.20% |
| 2021-12-31 | CN¥1.62 Billion ≈ $236.48 Million |
+11.12% |
| 2020-12-31 | CN¥1.45 Billion ≈ $212.81 Million |
+158.03% |
| 2019-12-31 | CN¥563.63 Million ≈ $82.48 Million |
+45.79% |
| 2018-12-31 | CN¥386.60 Million ≈ $56.57 Million |
+34.54% |
| 2017-12-31 | CN¥287.35 Million ≈ $42.05 Million |
+44.19% |
| 2016-12-31 | CN¥199.28 Million ≈ $29.16 Million |
+12.39% |
| 2015-12-31 | CN¥177.32 Million ≈ $25.95 Million |
+61.46% |
| 2014-12-31 | CN¥109.82 Million ≈ $16.07 Million |
+6.92% |
| 2013-12-31 | CN¥102.71 Million ≈ $15.03 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Titan Scientific Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9229.8% over the analyzed period, indicating profitable operations and earnings retention.
Shanghai Titan Scientific Co. Ltd. A Net Assets Breakdown (December 2025)
Shanghai Titan Scientific Co. Ltd. A net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥419.00 Million | 15.22% |
| Other Components | CN¥2.33 Billion | 84.78% |
| Total Equity | CN¥2.75 Billion | 100.00% |
Shanghai Titan Scientific Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shanghai Titan Scientific Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Huakong Seg Co Ltd
SHE:000068
|
$421.30 Million |
|
Shenzhen Emperor Technology Co Ltd
SHE:300546
|
$421.40 Million |
|
Community Healthcare Trust Inc
NYSE:CHCT
|
$421.50 Million |
|
init innovation in traffic systems SE
F:IXX
|
$421.73 Million |
|
BANK OG TIANJIN H YC1
F:B95
|
$420.85 Million |
|
Qingdao Huijintong Power
SHG:603577
|
$420.83 Million |
|
Ways Electron Co Ltd
SHG:605218
|
$420.69 Million |
|
Benitec Biopharma Ltd ADR
NASDAQ:BNTC
|
$420.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Titan Scientific Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,786,137,700 to 2,753,435,815, a change of -32,701,885 (-1.2%).
- Net loss of 13,044,348 reduced equity.
- Dividend payments of 56,531,725 reduced retained earnings.
- Other comprehensive income decreased equity by 115,516,712.
- Other factors increased equity by 152,390,899.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-13.04 Million | -0.47% |
| Dividends Paid | CN¥56.53 Million | -2.05% |
| Other Comprehensive Income | CN¥-115.52 Million | -4.2% |
| Other Changes | CN¥152.39 Million | +5.53% |
| Total Change | CN¥- | -1.17% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Titan Scientific Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.57x to 1.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥2.66 | CN¥17.50 | x |
| 2014-12-31 | CN¥2.84 | CN¥17.50 | x |
| 2015-12-31 | CN¥4.24 | CN¥17.50 | x |
| 2016-12-31 | CN¥4.56 | CN¥17.50 | x |
| 2017-12-31 | CN¥6.19 | CN¥17.50 | x |
| 2018-12-31 | CN¥3.94 | CN¥17.50 | x |
| 2019-12-31 | CN¥5.43 | CN¥17.50 | x |
| 2020-12-31 | CN¥12.14 | CN¥17.50 | x |
| 2021-12-31 | CN¥10.56 | CN¥17.50 | x |
| 2022-12-31 | CN¥17.57 | CN¥17.50 | x |
| 2023-12-31 | CN¥17.03 | CN¥17.50 | x |
| 2024-12-31 | CN¥17.29 | CN¥17.50 | x |
| 2025-12-31 | CN¥16.89 | CN¥17.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Titan Scientific Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.52%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.77x
- Recent ROE (-0.47%) is below the historical average (7.93%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.88% | 6.09% | 0.81x | 1.60x | CN¥-2.17 Million |
| 2014 | 6.33% | 3.71% | 1.06x | 1.60x | CN¥-4.03 Million |
| 2015 | 9.44% | 6.21% | 1.09x | 1.39x | CN¥-986.03K |
| 2016 | 13.83% | 6.74% | 1.14x | 1.79x | CN¥7.63 Million |
| 2017 | 13.42% | 5.80% | 1.47x | 1.57x | CN¥9.82 Million |
| 2018 | 15.52% | 6.47% | 1.41x | 1.70x | CN¥21.31 Million |
| 2019 | 13.15% | 6.48% | 1.23x | 1.65x | CN¥17.76 Million |
| 2020 | 7.15% | 7.42% | 0.75x | 1.29x | CN¥-41.04 Million |
| 2021 | 9.13% | 6.65% | 0.83x | 1.65x | CN¥-13.65 Million |
| 2022 | 4.59% | 4.79% | 0.66x | 1.46x | CN¥-147.16 Million |
| 2023 | 2.60% | 2.62% | 0.63x | 1.57x | CN¥-206.49 Million |
| 2024 | 0.46% | 0.45% | 0.59x | 1.74x | CN¥-265.72 Million |
| 2025 | -0.47% | -0.52% | 0.52x | 1.77x | CN¥-288.39 Million |
Industry Comparison
This section compares Shanghai Titan Scientific Co. Ltd. A's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $620,114,492
- Average return on equity (ROE) among peers: 11.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Titan Scientific Co. Ltd. A (688133) | CN¥2.79 Billion | 7.88% | 0.74x | $421.09 Million |
| North Huajin Chemical Industries Co Ltd (000059) | $1.29 Billion | -4.70% | 0.93x | $1.07 Billion |
| Sichuan Chemical Co Ltd (000155) | $1.46 Billion | 0.78% | 1.19x | $2.48 Billion |
| Jiangsu Wujiang China Eastern Silk Market Co Ltd (000301) | $1.34 Billion | -3.45% | 1.43x | $10.07 Billion |
| Zangge Holding Co Ltd (000408) | $44.66 Million | 14.35% | 2.09x | $15.25 Billion |
| Sichuan Jinlu Group Co Ltd (000510) | $250.86 Million | 12.61% | 0.84x | $909.16 Million |
| Jilin Gpro Titanium Industry Co Ltd (000545) | $24.25 Million | 13.70% | 13.57x | $277.26 Million |
| Aoyuan Beauty Valley Technology Co Ltd (000615) | $781.20 Million | 17.38% | 0.91x | $779.47 Million |
| Ningxia Younglight Chemicals Co Ltd (000635) | $31.53 Million | 19.31% | 2.12x | $547.90 Million |
| Maoming Petro-Chemical Shihua Co Ltd (000637) | $941.85 Million | 6.52% | 0.36x | $282.23 Million |
| Inner Mongolia Yuan Xing Energy Co Ltd (000683) | $30.43 Million | 38.29% | 2.28x | $3.33 Billion |
About Shanghai Titan Scientific Co. Ltd. A
Shanghai Titan Scientific Co., Ltd. engages in the provision of laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, laboratory construction, and scientific research information services. It serves universities, hospitals, research i… Read more